This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
 
Following its release of strong revenue growth for the fourth quarter and full-year 2006, Qiagen officials said this week that the firm plans to expand its sample and assay portfolio and expects to make “a significant investment in clinical trials” for new diagnostic products.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.